🫀 #REACT at #ESCCongress#Hotline
How early does atherosclerosis really begin?
16,808 adults, age 18–70 without known ASCVD underwent coronary, carotid & femoral imaging
🔎 Silent atherosclerosis: 57.1% overall
➡️ Already present in ~1 in 13 adults aged 18–29
➡️ ~9 in 10 by age 60–70!
💃🏻Women: steep rise during midlife, around menopausal transition; men developed atherosclerosis ~5–10 years earlier
🫀Atherosclerosis begins decades before clinical events—and often before conventional risk scores identify high risk. REACT should make us think about prevention much earlier
Next question: can imaging-guided early intervention actually prevent progression and events? Or should we just work to prevent CVD in everyone?
📄 @NEJM
https://t.co/rcQrmJz8Er
#ASCVD #Prevention #WomensHeartHealth #CVPrev
Had the most amazing opportunity to present a case at @escardio#ESCCongress 2026 in Munich! From the latest guidelines and hypertension management in special populations, to early research on stem cell therapy for ischemic cardiomyopathy, hearing from women leaders in cardiology about mentorship and sponsorship (@Drroxmehran ) l, and a virtual tour inside the heart — truly an enlightening few days of learning and connecting.
Thank you @kestonrattan@HamzaTarigHamza and Dr Samy McFarlane for letting me be part of the case and giving me the chance to present! 🫀
Hopefully this is the first of many!
Innovations in Heart Failure and Interventional Cardiology - Hot Line 6 & 7 👇
More #ESCCongress 2026 Hot Lines visual summaries are available here: https://t.co/UTqnyBqabR
#ESCCongress
A successful day of learning and thoughtful discussion with leaders in heart failure and cardiogenic shock. Grateful for the opportunity to engage with experts shaping the future of cardiovascular care. @KadoshBernard@ElizabethAlliMD@NazeeraGhanie@HamzaTarigHamza